| Ozark Family Medical Clinic, Llc | |
|
2725 N Westwood Blvd Ste 17 Poplar Bluff MO 63901-2367 | |
| (573) 686-5510 | |
| Not Available |
| Full Name | Ozark Family Medical Clinic, Llc |
|---|---|
| Speciality | Family Medicine |
| Location | 2725 N Westwood Blvd Ste 17, Poplar Bluff, Missouri |
| Authorized Official Name and Position | Ashley Tinsley (OWNER) |
| Authorized Official Contact | 5736865510 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Ozark Family Medical Clinic, Llc 2725 N Westwood Blvd Poplar Bluff MO 63901-2346 Ph: () - | Ozark Family Medical Clinic, Llc 2725 N Westwood Blvd Ste 17 Poplar Bluff MO 63901-2367 Ph: (573) 686-5510 |
| NPI Number | 1225810179 |
|---|---|
| Provider Enumeration Date | 10/16/2023 |
| Last Update Date | 10/16/2023 |
| Medicare PECOS PAC ID | 6002263449 |
|---|---|
| Medicare Enrollment ID | O20231130002525 |
News Archive
Three hospitals-Kobe University Hospital, Hyogo Prefectural Rehabilitation Central Hospital, and Meiwa Hospital-were jointly accredited as a Federation Internationale de Football Association Medical Centre of Excellence.
Medicines that carry warnings about sleep disturbances do not seem to contribute to the amount of sleep disturbances in the general population, according to new ‘real world' research.
A promising study from Rhode Island Hospital demonstrated that cholinesterase inhibitors, a type of medication often prescribed for Alzheimer's disease, improved some cognitive skills in patients with mild AD - skills that are necessary for driving. Findings from the study showed that after being treated with a ChEI, AD patients improved in some computerized tests of executive function and visual attention, including a simulated driving task.
Salix Pharmaceuticals, Ltd. today announced that NASDAQ has halted trading of the Company's common stock this morning. The Gastrointestinal Drugs Advisory Committee of the FDA is meeting today to discuss the efficacy and safety of the New Drug Application (NDA) for XIFAXAN® (rifaximin) Tablets, 550 mg for the maintenance of remission of hepatic encephalopathy.
› Verified 3 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1225810179 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | (* (Not Available)) | Primary |
| Provider Name | Linda Kay Blasingame |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1790233187 PECOS PAC ID: 4082989397 Enrollment ID: I20211230000065 |
News Archive
Three hospitals-Kobe University Hospital, Hyogo Prefectural Rehabilitation Central Hospital, and Meiwa Hospital-were jointly accredited as a Federation Internationale de Football Association Medical Centre of Excellence.
Medicines that carry warnings about sleep disturbances do not seem to contribute to the amount of sleep disturbances in the general population, according to new ‘real world' research.
A promising study from Rhode Island Hospital demonstrated that cholinesterase inhibitors, a type of medication often prescribed for Alzheimer's disease, improved some cognitive skills in patients with mild AD - skills that are necessary for driving. Findings from the study showed that after being treated with a ChEI, AD patients improved in some computerized tests of executive function and visual attention, including a simulated driving task.
Salix Pharmaceuticals, Ltd. today announced that NASDAQ has halted trading of the Company's common stock this morning. The Gastrointestinal Drugs Advisory Committee of the FDA is meeting today to discuss the efficacy and safety of the New Drug Application (NDA) for XIFAXAN® (rifaximin) Tablets, 550 mg for the maintenance of remission of hepatic encephalopathy.
› Verified 3 days ago
| Provider Name | Kimberly E Slayton |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1619444627 PECOS PAC ID: 0840623930 Enrollment ID: I20220628001620 |
News Archive
Three hospitals-Kobe University Hospital, Hyogo Prefectural Rehabilitation Central Hospital, and Meiwa Hospital-were jointly accredited as a Federation Internationale de Football Association Medical Centre of Excellence.
Medicines that carry warnings about sleep disturbances do not seem to contribute to the amount of sleep disturbances in the general population, according to new ‘real world' research.
A promising study from Rhode Island Hospital demonstrated that cholinesterase inhibitors, a type of medication often prescribed for Alzheimer's disease, improved some cognitive skills in patients with mild AD - skills that are necessary for driving. Findings from the study showed that after being treated with a ChEI, AD patients improved in some computerized tests of executive function and visual attention, including a simulated driving task.
Salix Pharmaceuticals, Ltd. today announced that NASDAQ has halted trading of the Company's common stock this morning. The Gastrointestinal Drugs Advisory Committee of the FDA is meeting today to discuss the efficacy and safety of the New Drug Application (NDA) for XIFAXAN® (rifaximin) Tablets, 550 mg for the maintenance of remission of hepatic encephalopathy.
› Verified 3 days ago
News Archive
Three hospitals-Kobe University Hospital, Hyogo Prefectural Rehabilitation Central Hospital, and Meiwa Hospital-were jointly accredited as a Federation Internationale de Football Association Medical Centre of Excellence.
Medicines that carry warnings about sleep disturbances do not seem to contribute to the amount of sleep disturbances in the general population, according to new ‘real world' research.
A promising study from Rhode Island Hospital demonstrated that cholinesterase inhibitors, a type of medication often prescribed for Alzheimer's disease, improved some cognitive skills in patients with mild AD - skills that are necessary for driving. Findings from the study showed that after being treated with a ChEI, AD patients improved in some computerized tests of executive function and visual attention, including a simulated driving task.
Salix Pharmaceuticals, Ltd. today announced that NASDAQ has halted trading of the Company's common stock this morning. The Gastrointestinal Drugs Advisory Committee of the FDA is meeting today to discuss the efficacy and safety of the New Drug Application (NDA) for XIFAXAN® (rifaximin) Tablets, 550 mg for the maintenance of remission of hepatic encephalopathy.
› Verified 3 days ago
Tinsley Home Medical Services, Llc Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 2725 N Westwood Blvd, Poplar Bluff, MO 63901 Phone: 573-686-5510 | |
Southern Missouri Sleep Center, Llc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 922 N Westwood Blvd, Poplar Bluff, MO 63901 Phone: 573-727-9661 Fax: 573-727-9665 | |
Southeasthealth Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 2002 Kanell Blvd, Poplar Bluff, MO 63901 Phone: 573-778-0020 Fax: 573-776-7548 | |
Mid-south Health Clinic Llc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 3100 Warrior Ln, Poplar Bluff, MO 63901 Phone: 573-785-0851 | |
Missouri Highlands Health Care Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 2210 Barron Rd Ste 120, Poplar Bluff, MO 63901 Phone: 573-785-6536 Fax: 573-785-0345 | |
Kneibert Clinic Llc Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 686 Lester St, Poplar Bluff, MO 63901 Phone: 573-686-2411 Fax: 573-686-8452 | |
Advanced Family Healthcare Clinic Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 2002 Kanell Blvd, Suite 101, Poplar Bluff, MO 63901 Phone: 573-778-9292 Fax: 573-778-0801 |